What is the Marksans Pharma Ltd FII shareholding?

Foreign Institutional Investors (FIIs) hold 19.06% of the total equity shares of Marksans Pharma Ltd.

What is the Marksans Pharma Ltd DII shareholding?

Domestic Institutional Investors (DIIs) hold 5.54% of the total equity shares of Marksans Pharma Ltd.

How has the Marksans Pharma Ltd promoter holding changed?

The promoter holding in Marksans Pharma Ltd changed from 43.87% to 43.87% during the latest reported period.

How has the Marksans Pharma Ltd FII holding changed?

The FII holding in Marksans Pharma Ltd changed from 17.47% to 19.06% during the latest reported period.

How has the Marksans Pharma Ltd DII holding changed?

The DII holding in Marksans Pharma Ltd changed from 6.19% to 5.54% during the latest reported period.

Who are the major shareholders of Marksans Pharma Ltd?

The major shareholders of Marksans Pharma Ltd may include promoters, institutional investors and other significant shareholders holding substantial equity stakes.

Marksans Pharma Ltd Shareholding Pattern: Promoters, FII, DII & Public

Q: What is the Marksans Pharma Ltd public shareholding?

Public shareholders hold 31.53% of the total equity shares of Marksans Pharma Ltd as per the latest available data.

Marksans Pharma Ltd Share Price

Detail Overview

Pharmaceuticals - Indian - FormulationsNSE

₹286.90

-7.55(-2.56%)

As on 23 Oct 2026 at 15:54

As of 23 Oct 2026 at 15:54, Marksans Pharma Ltd is trading at ₹286.90. The 52-week range stands at ₹155.00–₹350.95, with a market cap of ₹12.99 thousand crore. At a P/E of 40.39 and a dividend yield of 0.31%, it is a mid-cap stock in the Pharmaceuticals sector.